Company news

Somnomed Limited news in 2024

Somnomed Limited's news releases, calls and decks from 2024, newest first.

View company

AGM Chairman & co-CEO addresses

November 26, 2024

Investor Presentation AGM

November 26, 2024

FY25 Guidance Upgrade and Appointment of CFO

November 26, 2024

Rest Assure - US Food and Drug Authority (FDA) Update

October 6, 2024

Investor Presentation

August 27, 2024

FY24 Preliminary Report and FY25 Guidance

August 27, 2024

Preliminary Final Report

August 27, 2024

Completion of retail component of Entitlement Offer

May 3, 2024

Replacement Prospectus

April 15, 2024

Reinstatement to Quotation

April 10, 2024

Completion of institutional component of Entitlement Offer

April 10, 2024

Revised guidance and capital raising

April 8, 2024

Prospectus Entitlement Offer

April 8, 2024

Update on voluntary suspension & FY24 earnings guidance

April 4, 2024

Suspension from Quotation

April 2, 2024

Trading Halt

March 26, 2024

Solid start in 1H as core business revenues increase 13%

February 27, 2024

Appointment of Co-CEO's

February 22, 2024

Decks in 2024